Aims Patients with heart failure (HF) randomized in controlled trials are generally selected
and do not fully represent the 'real world'. The purpose of this study is to better describe the …

Aims To evaluate how recommendations of European guidelines regarding
pharmacological and non‐pharmacological treatments for heart failure (HF) are adopted in …

Aims Surveys on heart failure management suggest under-utilization of life-saving evidence-
based treatment. Evidence-based medicine and clinical guidelines are based on the results …

Abstract Aims The European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐
HF‐LT‐R) was set up with the aim of describing the clinical epidemiology and the 1‐year …

Background—Clinical observational studies on heart failure (HF) deal mostly with
hospitalized patients, few with chronic outpatients, all with no or limited longitudinal …

Background Recent registries have shown that recommended drugs for the treatment of
chronic heart failure (CHF) are under‐prescribed in daily practice. Aims To determine …

Background Angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor
blockers (ARBs), β blockers, and mineralocorticoid receptor antagonists (MRAs) are of …

Background—Although the absolute benefits of an intervention are proportional to patients'
underlying risk, studies in heart failure have noted a paradoxical inverse relationship …

Background Adherence to treatment guidelines affects outcomes in patients with chronic
heart failure (HF). We investigated patient pathways and treatment patterns for HF in …

Chronic heart failure (CHF) is associated with a heavy burden of disease for patients and
healthcare professionals. Quality of life and long-term prognosis for affected patients remain …